SILO Pharma Inc [SILO] stock prices are down -9.20% to $0.58 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The SILO shares have gain 30.76% over the last week, with a monthly amount drifted -28.26%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
The stock price of SILO Pharma Inc [SILO] has been fluctuating between $0.41 and $4.50 over the past year. SILO Pharma Inc [NASDAQ: SILO] shares were valued at $0.58 at the most recent close of the market.
Analyzing the SILO fundamentals
Gross Profit Margin for this corporation currently stands at 0.92% with Operating Profit Margin at -68.24%, Pretax Profit Margin comes in at -64.11%, and Net Profit Margin reading is -64.11%. To continue investigating profitability, this company’s Return on Assets is posted at -15.63, Equity is -0.85 and Total Capital is 5.53.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.5107 points at the first support level, and at 0.4404 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.7207, and for the 2nd resistance point, it is at 0.8604.
Ratios To Look Out For
It’s worth pointing out that SILO Pharma Inc [NASDAQ:SILO]’s Current Ratio is 4.73. As well, the Quick Ratio is 4.73, while the Cash Ratio is 2.65. Considering the valuation of this stock, the price to sales ratio is 59.86, the price to book ratio is 0.65.
Transactions by insiders
Recent insider trading involved Weisblum Eric, Chief Executive Officer, that happened on May 27 ’25 when 10000.0 shares were purchased. CEO and President, Weisblum Eric completed a deal on Dec 13 ’24 to buy 2500.0 shares. Meanwhile, CEO and President Weisblum Eric bought 2500.0 shares on Nov 20 ’24.
